×
Back to Agenda
New Changes to the National Drug Code in the U.S.
Session Chair(s)
Leyla Rahjou-Esfandiary, PharmD
Lead CSO, Office of Compliance, CDER
FDA, United States
New Changes to the National Drug Code in the U.S.
Have an account?